Two clinical trials combining radiation with immunotherapy are under way and a third will begin recruiting patients with triple negative breast cancer later this year, researchers said.
"Using radiation first in aggressive breast cancer, followed by immunotherapy to amplify the immune response, to cancer was an 'emerging idea'," said Sherene Loi, associate professor Peter MacCallum Cancer Centre in Australia.
The trials follow promising animal studies, where radiation was successfully used to 'prime' the immune system for it to take over the cancer fight, 'The Herald Sun' reported.
"Once you develop cancer your immune system has failed. It can not see the cancer any more, and it also actively suppresses the immune system," Loi said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
